Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effect and Tolerability of Atorvastatin Versus Placebo in Patients With Pulmonary Hypertension: Double-blinded, Randomised, Prospective Phase II Study for 6 Months With Adjusted Doses of Atorvastatin

NCT00615823 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor.

NCT NCT00615823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00615823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effect and Tolerability of Atorvastatin Versus Placebo in Patients With Pulmonary Hypertension: Double-blinded, Randomised, Prospective Phase II Study for 6 Months With Adjusted Doses of Atorvastatin
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
May 31, 2010
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, pulmonary